|
FAM83G expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.563060E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.037810E-03 |
| Normal-vs-Stage2 |
5.89359999999539E-05 |
| Normal-vs-Stage3 |
4.663000E-01 |
| Normal-vs-Stage4 |
1.098190E-01 |
| Stage1-vs-Stage2 |
1.540160E-01 |
| Stage1-vs-Stage3 |
1.538770E-01 |
| Stage1-vs-Stage4 |
7.841400E-01 |
| Stage2-vs-Stage3 |
2.194500E-02 |
| Stage2-vs-Stage4 |
3.423600E-01 |
| Stage3-vs-Stage4 |
5.185800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.207000E-04 |
| Normal-vs-AfricanAmerican |
3.003200E-03 |
| Normal-vs-Asian |
8.791400E-01 |
| Caucasian-vs-AfricanAmerican |
7.007800E-01 |
| Caucasian-vs-Asian |
3.117600E-01 |
| AfricanAmerican-vs-Asian |
3.480600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.50799999999651E-05 |
| Normal-vs-Female |
2.172600E-01 |
| Male-vs-Female |
2.216700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.135900E-02 |
| Normal-vs-Extreme_Weight |
3.69580000003644E-06 |
| Normal-vs-Obese |
2.532300E-02 |
| Normal-vs-Extreme_Obese |
1.657080E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.475010E-01 |
| Normal_Weight-vs-Obese |
7.281600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.638830E-01 |
| Extreme_Weight-vs-Obese |
2.440400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.180400E-01 |
| Obese-vs-Extreme_Obese |
6.634000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.634000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.098010E-02 |
| Normal-vs-Age(61-80Yrs) |
5.31840000039807E-07 |
| Normal-vs-Age(81-100Yrs) |
3.96330002150336E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.484400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.013800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.762400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.144900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.77890002307191E-09 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.18200000000102E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.03110000004847E-06 |
| Normal-VS-Type2 PRCC |
2.394400E-02 |
| Normal-VS-KIRP CIMP |
7.094000E-01 |
| Normal-VS-Unclassified PRCC |
1.447410E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.032300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.978980E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.595900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.862800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.627600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.736200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.001400E-04 |
| Normal-vs-N1 |
9.901200E-01 |
| Normal-vs-N2 |
7.130400E-01 |
| N0-vs-N1 |
4.539800E-02 |
| N0-vs-N2 |
2.330400E-01 |
| N1-vs-N2 |
8.432400E-01 |
|
|
